Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Molecular and Clinical Oncology
|
November 15, 2021
Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma
Kohei Tamura, Yuji Takei, Shigeki Matsubara, et al.
Oncology Letters
|
July 12, 2012
Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma
Hiroyuki Fujiwara, Toshiko Jobo, Yuji Takei, et al.
Congenital Anomalies
|
April 19, 2024
A novel variant in IFT122 associated with a severe phenotype of cranioectodermal dysplasia
Shiho Nagayama, Hironori Takahashi, Fuyuki Hasegawa, et al.
International Journal of Oncology
|
November 27, 2010
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion
Hiroaki Nonaka, Yasushi Saga, Hiroyuki Fujiwara, et al.
The Journal of Obstetrics and Gynaecology Research
|
August 17, 2016
Prognosis of endometrial cancer patients with and without symptoms at recurrence
Takahiro Yoshiba, Yuji Takei, Shizuo Machida, et al.
Cancer Science
|
February 20, 2016
Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
Yoshifumi Takahashi, Yasushi Saga, Takahiro Koyanagi, et al.
International Journal of Clinical Oncology
|
April 22, 2018
Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma
Yuji Takei, Suzuyo Takahashi, Shizuo Machida, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 11, 2015
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
Hiroaki Itamochi, Nao Oumi, Tetsuro Oishi, et al.
International Journal of Molecular Sciences
|
November 27, 2025
Determination of the Number of Circulating Small Extracellular Vesicles in Pregnancy Using the Novel Marker CD9
Risa Narumi, Hirotada Suzuki, Manabu Ogoyama, et al.
International Journal of Oncology
|
October 14, 2015
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
Yoshifumi Takahashi, Yasushi Saga, Takahiro Koyanagi, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Molecular and Clinical Oncology
|
November 15, 2021
Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma
Kohei Tamura, Yuji Takei, Shigeki Matsubara, et al.
Oncology Letters
|
July 12, 2012
Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma
Hiroyuki Fujiwara, Toshiko Jobo, Yuji Takei, et al.
Congenital Anomalies
|
April 19, 2024
A novel variant in IFT122 associated with a severe phenotype of cranioectodermal dysplasia
Shiho Nagayama, Hironori Takahashi, Fuyuki Hasegawa, et al.
International Journal of Oncology
|
November 27, 2010
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion
Hiroaki Nonaka, Yasushi Saga, Hiroyuki Fujiwara, et al.
The Journal of Obstetrics and Gynaecology Research
|
August 17, 2016
Prognosis of endometrial cancer patients with and without symptoms at recurrence
Takahiro Yoshiba, Yuji Takei, Shizuo Machida, et al.
Cancer Science
|
February 20, 2016
Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
Yoshifumi Takahashi, Yasushi Saga, Takahiro Koyanagi, et al.
International Journal of Clinical Oncology
|
April 22, 2018
Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma
Yuji Takei, Suzuyo Takahashi, Shizuo Machida, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 11, 2015
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
Hiroaki Itamochi, Nao Oumi, Tetsuro Oishi, et al.
International Journal of Molecular Sciences
|
November 27, 2025
Determination of the Number of Circulating Small Extracellular Vesicles in Pregnancy Using the Novel Marker CD9
Risa Narumi, Hirotada Suzuki, Manabu Ogoyama, et al.
International Journal of Oncology
|
October 14, 2015
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
Yoshifumi Takahashi, Yasushi Saga, Takahiro Koyanagi, et al.
Page
of 18